A validated method of labial minor salivary gland biopsy for the diagnosis of Sjögren's syndrome.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 27107215.
- Also identified by DOI 10.1002/lary.25974.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To validate a technique and outcomes of labial minor salivary gland biopsy (LSGB) used for the diagnosis of Sjögren's syndrome (SS). Prospective cohort study. Clinical data were prospectively obtained pre- and postbiopsy using patient-reported questionnaires. LSGB was performed using described methods. Specimens were analyzed by a pathologist with expertise in SS and assessed using established criteria to determine the focus score. Data were analyzed using cross-tabulations. Among the 58 patients in the study, 52 (90%) presented with sicca symptoms of dry eyes and/or mouth. Eight patients (14%) had histopathologic findings supportive of a diagnosis of SS. At 1 month postbiopsy, greater than 71% of patients denied any complaints of pain, swelling, numbness. or tingling. Sixteen patients (28%) had only a minor level of complaints. Only one patient complained of severe numbness at the biopsy site. Greater than 70% of patients would consider rebiopsy after the procedure, if requested by their physician. We present a safe and effective method of LSGB for the diagnosis of SS. 4 Laryngoscope, 126:2041-2046, 2016.
Medical subject headings
- Lip
- Salivary Glands, Minor
- Sjogren's Syndrome